2011 annual financial data
BioCryst Pharmaceuticals 2011 Operating margin
Direct answer
Operating margin was -252.44%.
Operating income was -49,587,000 USD and net income was -56,948,000 USD.
Operating cash flow was -32,251,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,643,000 USD
- Operating income
- -49,587,000 USD
- Net income
- -56,948,000 USD
- Operating cash flow
- -32,251,000 USD